Cart
Free US shipping over $10
Proud to be B-Corp

Diagnosis and Management in Parkinson's Disease Summary

Diagnosis and Management in Parkinson's Disease: The Neuroscience of Parkinsons Disease, Volume 1 by Colin R Martin, RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci (Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director Institute for Health and Wellbeing, University of Suffolk, Ipswich, UK)

Diagnosis and Management in Parkinson's Disease: The Neuroscience of Parkinsons, Volume 1 provides a single source of material covering different scientific domains of neuropathology underlying this condition. The book covers a wide range of subjects and unravels the complex relationships between genetics, molecular biology, pharmaceutical chemistry, neurobiology, imaging, assessments, and treatment regimens. It fills a much-needed gap as a "one-stop" synopsis of everything concerning the neurology and neuroscience related to Parkinsons disease, from chemicals and cells to individuals. The book is an invaluable resource for neuroscientists, neurologists, and anyone in the field.

About Colin R Martin, RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci (Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director Institute for Health and Wellbeing, University of Suffolk, Ipswich, UK)

Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collaborative International research with many European and Non-European countries. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at Kings College Hospital and Emeritus Professor of Nutritional Biochemistry at Kings College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at Kings College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

Table of Contents

Section 1: Parkinsons Disease: Introductory Chapters 1. A Short History of Parkinsons Disease from early 19th century and afterwards an overview2. Living with Parkinsons disease from financial to emotional3. The epidemiology of Parkinsons disease an overview4. Clinical Features of Parkinsons disease an overview5. The natural history of Parkinsons disease an overview6. The prognosis of Parkinsons disease an overview7. The neurobiology of Parkinsons disease an overview8. The pathophysiology of Parkinsons disease an overview9. Molecular and cellular mechanisms associated with Parkinsons disease synuclein, amyloid protein, oligomers and beyond10. Quality of life in Parkinsons disease11. Gait in untreated Parkinsons disease12. Levodopa-induced dyskinesias13. Tremor in Parkinsons disease14 The impact of Parkinsons disease on the family and careers Section 2: Biomarkers and Diagnosis15. Tissue biopsies as biomarkers in Parkinsons disease16. Spinal fluid for biomarker discovery in Parkinsons disease17. Clinical biomarkers in prodromal Parkinsons disease18. The diagnosis of Parkinson's disease19. Proteomics in Parkinsons disease20. MicroRNAs as biomarkers in Parkinsons diseases21. Phenotyping in Parkinsons disease22. Diagnosis of speech disorders in Parkinsons disease23. Identifying dementia in Parkinsons disease 24. Diagnosis of sleep disturbances in Parkinsons disease25. Diagnosis of Parkinsons disease using magnetic resonance imaging26. Use of ultrasound as a diagnostic tool in Parkinsons disease27. Use of single-photon emission computerized tomography (SPECT) as a diagnostic tool in Parkinsons disease28. Use of positron emission tomography (PET) as a diagnostic tool in Parkinsons disease Section 3: Pharmacological Treatments for Parkinsons Disease29. Dopamine Agonists and Parkinsons disease an overview30. Management with Levodopa in Parkinsons disease31. Management with ripinirole in Parkinsons disease32. Management with pramipexole in Parkinsons disease33. Management with rotigotine in Parkinsons disease34. Management with apomorphine in Parkinsons disease35. Management with MAO-B Inhibitors in Parkinsons disease36. Management with COMT inhibitors in Parkinsons disease37. Management with anticholinergics in Parkinsons disease38. Management with amantadine in Parkinsons disease Section 4: Novel and Non-Pharmacological Therapies For Parkinsons Disease39. Treatment with chelator in Parkinsons disease40. Treatment with deep brain stimulation in Parkinsons disease41. Olive leaf extract usage as an antioxidant and applications to Parkinsons disease42. Treatment with Vitamin D for Parkinsons disease43. Chemogenetics and applications for Parkinsons disease44. Flavonoids and naringin usage in Parkinsons disease45. Stem cells and applications to Parkinsons disease46. Treatment with cannabis for Parkinsons disease47. Treating sleep problems in Parkinsons disease48. Perioperative treatments of Parkinsons disease49. Exercise and Parkinsons disease50. Molecular aspects: CB2 receptors and neuroprotection in Parkinsons disease

Additional information

NPB9780128159460
9780128159460
0128159464
Diagnosis and Management in Parkinson's Disease: The Neuroscience of Parkinsons Disease, Volume 1 by Colin R Martin, RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci (Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director Institute for Health and Wellbeing, University of Suffolk, Ipswich, UK)
New
Hardback
Elsevier Science Publishing Co Inc
2020-10-30
782
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Diagnosis and Management in Parkinson's Disease